Site icon pharmaceutical daily

The Worldwide Laboratory Freezers Industry is Expected to Reach $7.2 Billion by 2030: Rising Demand for Lab Freezers Due to its Proper Temperature-Controlled Storage of COVID-19 Vaccines Drives Growth – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Laboratory Freezers Market Share, Size, Trends, Industry Analysis Report, End-Use , By Product; By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global laboratory freezers market size is expected to reach USD 7.20 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

Companies Mentioned

The key factors responsible for the market growth include the rapidly rising demand for lab freezers due to its proper temperature-controlled storage of COVID-19 vaccines. The range of laboratories, COVID-19 trying out locations, and processing centers handling SARS-CoV-2 samples, reagents, and vaccinations increased exponentially as the COVID-19 spread worldwide. As a result, the need for laboratory refrigerators, freezers, and low-temperature freezers has risen to aid pattern processing, checking out, and vaccine improvement laboratories.

New general-purpose laboratory refrigerators and freezers provide reliable refrigeration capabilities while promoting a quiet working environment for clinical and industrial laboratories looking for technologies that can meet sustainability goals and maintain material safety. The TSG Series is designed to protect general research and clinical materials in a consistent manner, with temperature ranges that meet both short- and long-term storage requirements, including COVID-19 vaccine storage regulations.

Based on end-use, the blood banks segment accounted for the leading share in the market in 2021. The increasing prevalence of blood disorders including sickle-cell anemia, blood cancer, and haemophilia, is driving demand for whole blood and blood components, which is driving growth in this end-use sector. The majority of patients with hemophilia in the US are diagnosed when they are very young.

As per the Centers for Disease Control and Prevention (CDC), the median age at diagnosis for persons with mild haemophilia is 36 months, eight months for moderate haemophilia, and one month for severe haemophilia. Hemophilia is diagnosed using a particular blood test, and most babies can be screened shortly after delivery. The rising vaccine development for the emerging infectious disease and rising cases of organ transplantations is driving the laboratory freezers industry during the forecast period.

In the future, this increased focus and expenditure on vaccine development will fuel the growth of clinical research trials for vaccines. Organ transplantation procedures are becoming more common, demanding the preservation of organs under precise cooling settings to keep them healthy, make them available for treatments, and promote market growth. According to Organdonor.gov, around 39,000 transplants will be performed in 2020.

The publisher has segmented the laboratory freezers market report on the basis of product, end-use, and region.

Laboratory Freezers, Product Outlook

Laboratory Freezers, End-Use Outlook

Laboratory Freezers, Regional Outlook

For more information about this report visit https://www.researchandmarkets.com/r/rwspnz

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version